title: In Vitro andIn Vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
abstract: It has been well established that bone morphogenetic protein-2 (BMP-2) can induce bone formation bothin vivo andin vitro, although high concentrations (up to milligrams) of BMP-2 have been required to achieve this effectin vivo. Further, clinical applications are usually limited to a single dose at the time of implantation. In an attempt to prolong the transforming effect of BMP-2 we used a recombinant adenoviral vector carrying the human BMP-2 gene (Adv-BMP2) to transduce marrow-derived mesenchymal stem cells (MSC) of skeletally mature male New Zealand white rabbits. The pluripotential MSC were incubated with Adv-BMP2 overnight followed by culture in growth medium for 1 week. Assays on tissue cultures demonstrated that these Adv-BMP2 transduced MSC produced BMP-2 protein, differentiated into an osteoprogenitor line, and induced bone formationin vitro. These MSC had increased alkaline phosphatase activity, increased expression of type I collagen, osteopontin, and osteocalcin mRNA, and induced matrix mineralization compared with both nontransduced cells and cells transduced with a control adenoviral construct. To analyze the osteogenic potentialin vivo, Adv-BMP2-transduced MSC were autologously implanted into the intertransverse process space between L5 and L6 of the donor rabbits. The production of new bone was demonstrated by radiographic examination 4 weeks later in areas implanted with cells transduced with Adv-BMP2, whereas no bone was evident at sites implanted with cells transduced with the control adenoviral construct. Histological examination further confirmed the presence of new bone formation. These accumulated data indicate that it is possible to successfully transduce mesenchymal stem cells with a recombinant adenoviral vector carrying the gene for BMP-2 such that these cells will produce BMP-2, differentiate into an osteoprogenitor line, and induce bone formation bothin vitro andin vivo. Moreover, incubation of the Adv-BMP2-transduced cells for an additional 7 days in culture before transplantation enhances the success rate in bone formation (three out of three) as compared with our previous report (one out of five, Calcif Tissue Int 63:357-360, 1998).
authors.affiliation: Division of Bone and Mineral Diseases, Dept. of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: S-L
authors.initials: SL
authors.lastname: Cheng
authors.affiliation: Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: J
authors.initials: J
authors.lastname: Lou
authors.affiliation: Division of Bone and Mineral Diseases, Dept. of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.|Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: N M
authors.initials: NM
authors.lastname: Wright
authors.affiliation: Division of Bone and Mineral Diseases, Dept. of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: C F
authors.initials: CF
authors.lastname: Lai
authors.affiliation: Division of Bone and Mineral Diseases, Dept. of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.|Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: L V
authors.initials: LV
authors.lastname: Avioli
authors.affiliation: Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: K D
authors.initials: KD
authors.lastname: Riew
keywords: Adenovirus; BMP-2; Gene therapy; Mesenchymal stem cells; Spine fusion